EP Patent

EP2382976A1 — Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer

Assigned to Hiroshima University NUC · Expires 2011-11-02 · 15y expired

What this patent protects

The present invention relates to the use of PDGF-R inhibitors for the treatment of lymph node metastasis of gastric cancers and to a method of treating mammals including humans suffering from gastric cancer.

USPTO Abstract

The present invention relates to the use of PDGF-R inhibitors for the treatment of lymph node metastasis of gastric cancers and to a method of treating mammals including humans suffering from gastric cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP2382976A1
Jurisdiction
EP
Classification
—
Expires
2011-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Hiroshima University NUC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.